Lindsey George: Blood Study Links AAV-Derived FVIII Activity to Clinical Outcomes
Lindsey George, Assistant Professor of Pediatrics at University of Pennsylvania, Director of Clinical In Vivo Gene Therapy at Children’s Hospital of Philadelphia, shared Anna R. Sternberg’s post on LinkedIn:
“Congrats on seeing this through Anna and to all co-authors on this work!
Here we investigated the biochemical function of transgene-derived FVIII post AAV gene transfer as well as its hemostatic function in mice and relative correlation with clinical data.”
Anna R. Sternberg, Research Associate Scientist at Children’s Hospital of Philadelphia, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Blood, adding:
“6 years in the making with Lindsey George.
The pre-print for our research understanding the biochemical mechanism behind the AAV-derived FVIII assay discrepancy observed in patients is now available to read in Blood!”
Title: One-stage Assay Factor VIII Activity Reflects AAV-Derived Factor VIII-Enhanced Thrombin Activation and Predicts Phenotype
Authors: Anna R Sternberg, Connor T. Watson, Robert J Davidson, Marianne Uguen, Anna Kiialainen, Lindsey A. George

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian